Search Results
Results found for "cAM SINH LU"
- G protein-coupled receptors that influence lifespan of human and animal models
protein-coupled receptors (GPCRs) may be a good option to try to prolong our life while maintaining good health since
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
Moreover, since pharmacological tools to study PKC isozymes generally lack specificity and/or potency
- GPCR Happy Hour – Boston, Sept 2025
Sponsors This event would not be possible without the generous support of our sponsors: NIS Proteos Since
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition
- Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin...
However, controversy remains regarding its role in breast cancer since both pro- and anti-metastatic
- Glyco-sulfo hotspots in the chemokine receptor system
interactions between the negative sulfate groups in the N-terminus and the positively charged chemokines (Ludeman removal are ruled out it is possible that indirect effects may also contribute to the observed phenotype since
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
This interest has been driving efforts to understand their pharmacology since the 1980s.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
drugs, however they often have serious side effects and too low or temporary therapeutic effects.[3,4] Since Since BBVs lack downstream signaling, doing a quantitative lice-cell assay using the same ligand would G.; Puri, V.; Singh, R. D.; Hanada, K.; Pagano, R. E.; Miller, L. J.
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
Reference Roy, S., Sinha, S., Silas, A. J., Ghassemian, M., Kufareva, I., & Ghosh, P. (2024).
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
As part of these updates, a pricing adjustment is planned for 2026 — the first since Premium launched
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Most of them are small molecules capable of going through the BBB , and since their targets are on the
- Why Opposing Processes Matter for Your Next GPCR Drug
One wrong assumption about how your molecule behaves in a living system can sink months of work and millions
- 📰 GPCR Weekly News, September 11 to 17, 2023
Since you are reading this newsletter, you only have to click on the event page to join us.
- VAMP2: a crucial player in the delivery of MOR to the synapse
Since MOR receptor regulates pain perception and reward, the dysfunction in the MOR-SNARE complex interaction
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
GPCR dimers are very attractive molecular entities since they have been found to drive biased signalling
- Chemokine receptor-targeted drug discovery: progress and challenges
Signaling bias can be seen as complex as advantageous since selectively inhibiting certain signaling
- New role of β-arrestins in MOR signaling
However, opioids that prevent recruiting β-arrestin 2 do not address the problem since ligands that only
- How Collaboration Drives GPCR Discoveries
In research, including the GPCR world collaboration isn’t a luxury. It’s survival.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
The Quick Glance: pA₂ as Shortcut Sometimes, discovery projects don’t have the luxury of full curve analyses
- How GPCR Collaboration Built an Innovation Engine
This wasn’t luck. It was designed. “There was a bit of luck,” she admits. But luck alone doesn’t sustain an ecosystem. What mattered was how leadership leveraged luck into durable structure — through funding strategies, It’s a competitive advantage. 🎧 Listen to the full episode: Leadership, Luck, and GPCR Signaling 🔓
- From Pipettes to Platforms: The Evolution of GPCR Research
Leadership, Luck, and the Lab The episode isn’t just about technology — it’s also about how careers are
- How GPCR Spatial Signaling Sparked a Scientific Journey
Luck, Leadership & GPCR Signaling Michelle is clear: luck played a role. But so did choice. It’s easy to call it luck. But luck only works if you say yes when the door opens.
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
Pipeline efficiency isn’t luck—it’s literacy.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
It wasn’t luck. It was persistence.
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
challenges Decades of insight distilled into frameworks you can apply immediately Pipeline efficiency isn’t luck—it
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Luc Van Hijfte and Dr. Wendy Young.
- Conjugation Strategies for Probe Development
This is Lucía from the Celtarys Research chemistry team.
- Overview of adhesion GPCRs self-activation
a structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling, since
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
“The first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration
- Antibodies That Don’t Block, They Activate: A New Angle on Autoimmunity and GPCRs
The Tools to Detect Them Using the multiplexed GPCR library and Luminex assay , researchers can now:


















